Simplex Trading, LLC Acadia Pharmaceuticals Inc Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$14.62 - $18.42 $150,088 - $189,099	-10,266 Reduced 17.89%	47,110 $765,000
Q1 2024 Apr 25, 2024	SELL	$17.79 - $30.86 $53,174 - $92,240	-2,989 Reduced 4.95%	57,376 $1.06 Million
Q4 2023 Feb 02, 2024	SELL	$20.78 - $31.77 $395,297 - $604,360	-19,023 Reduced 23.96%	60,365 $1.89 Million
Q3 2023 Nov 01, 2023	BUY	$20.84 - $33.47 $1.65 Million - $2.66 Million	79,388 New	79,388 $1.65 Million
Q4 2022 Feb 02, 2023	SELL	$14.2 - $18.63 $134,928 - $177,022	-9,502 Reduced 64.19%	5,300 $84,000
Q3 2022 Nov 04, 2022	BUY	$14.11 - $18.27 $134,073 - $173,601	9,502 Added 179.28%	14,802 $242,000
Q2 2022 Aug 03, 2022	SELL	$13.01 - $27.22 $153,518 - $321,196	-11,800 Reduced 69.01%	5,300 $74,000
Q1 2022 May 02, 2022	SELL	$20.94 - $27.5 $1.45 Million - $1.91 Million	-69,293 Reduced 80.21%	17,100 $414,000
Q4 2021 Feb 23, 2022	BUY	$16.79 - $27.09 $588,338 - $949,260	35,041 Added 68.24%	86,393 $2.02 Million
Q3 2021 Oct 28, 2021	BUY	$15.78 - $24.77 $3,156 - $4,954	200 Added 0.39%	51,352 $1.27 Million
Q2 2021 Aug 12, 2021	SELL	$19.4 - $27.42 $770,277 - $1.09 Million	-39,705 Reduced 43.7%	51,152 $1.25 Million
Q1 2021 Apr 26, 2021	BUY	$25.02 - $54.99 $1.73 Million - $3.81 Million	69,239 Added 320.28%	90,857 $2.34 Million
Q4 2020 Feb 02, 2021	SELL	$41.04 - $56.79 $17,524 - $24,249	-427 Reduced 1.94%	21,618 $0
Q3 2020 Oct 14, 2020	BUY	$36.42 - $57.0 $802,878 - $1.26 Million	22,045 New	22,045 $0
Q2 2020 Jul 13, 2020	SELL	$39.26 - $52.73 $425,342 - $571,276	-10,834 Closed	0 $0
Q1 2020 Apr 29, 2020	SELL	$31.65 - $46.87 $507,033 - $750,857	-16,020 Reduced 59.66%	10,834 $457,000
Q4 2019 Feb 05, 2020	SELL	$36.21 - $51.4 $1.48 Million - $2.11 Million	-40,966 Reduced 60.4%	26,854 $1.15 Million
Q3 2019 Oct 15, 2019	BUY	$22.22 - $44.01 $772,700 - $1.53 Million	34,775 Added 105.24%	67,820 $0
Q2 2019 Jul 26, 2019	SELL	$23.32 - $28.12 $819,371 - $988,024	-35,136 Reduced 51.53%	33,045 $883,000
Q1 2019 Apr 18, 2019	BUY	$16.17 - $27.38 $546,626 - $925,580	33,805 Added 98.34%	68,181 $0
Q4 2018 Jan 16, 2019	SELL	$14.32 - $22.92 $9,981 - $15,975	-697 Reduced 1.99%	34,376 $555,000
Q3 2018 Oct 23, 2018	BUY	$13.03 - $21.81 $124,110 - $207,740	9,525 Added 37.28%	35,073 $728,000
Q2 2018 Jul 30, 2018	BUY	$15.07 - $22.34 $385,008 - $570,742	25,548 New	25,548 $390,000
Q1 2018 Apr 26, 2018	SELL	$22.47 - $32.33 $226,430 - $325,789	-10,077 Closed	0 $0
Q4 2017 Jan 10, 2018	SELL	$26.84 - $39.14 $299,239 - $436,371	-11,149 Reduced 52.53%	10,077 $303,000
Q3 2017 Oct 25, 2017	BUY	$29.49 - $38.37 $625,954 - $814,441	21,226	21,226 $799,000

Others Institutions Holding ACAD

# of Institutions

279

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account